Davutamig (REGN-5093) is a human IgG4-kappa monoclonal bispecific antibody designed to target two distinct, non-overlapping epitopes on the MET receptor. This antibody functions as an antineoplastic agent, primarily utilized in cancer research and therapy. Its unique bispecific nature allows for enhanced specificity and efficacy in targeting the MET receptor, a critical player in the pathology of various cancers.
Davutamig (REGN-5093) is a human IgG4-kappa monoclonal bispecific antibody designed to target two distinct, non-overlapping epitopes on the MET receptor. This antibody functions as an antineoplastic agent, primarily utilized in cancer research and therapy. Its unique bispecific nature allows for enhanced specificity and efficacy in targeting the MET receptor, a critical player in the pathology of various cancers.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
